Clinical Pharmacy Associates provides solutions for hospitals, other healthcare institutions, nursing homes and managed care providers to realize the benefits of superior pharmacy and medication management in the new era of accountable healthcare.
Independent and unbiased, we are an organization comprised of skilled, experienced clinical pharmacists, physicians, nurses and engineers. The extraordinary level of expertise we bring to our clients makes us especially adept at:
- Providing answers to drug information problems
- Drug utilization and formulary support through P&T management services
- Patient outcomes management and analysis
- Optimizing pharmacy services
- Management and technical consulting
- Education and training
- Medication error prevention and risk mitigation programs
- Outsourcing clinical and management expertise
- Medication-related technology strategic planning, implementation support and remediation
- Strategic planning for pharmacy operations
- Accreditation preparedness for medication management
Clinical Pharmacy Associates was founded in 1986 by Dr. Christopher Keeys, Pharm.D., R.Ph., BCPS and Kenneth Dandurand, M.S., R.Ph. The two of them met at Greater Southeast Community Hospital, Washington, DC, where they led the Pharmacy Department of this 450-bed hospital. At the time, they believed hospitals stood to benefit from having access to an independent, unbiased company that offered pharmacy leadership and drug information solutions. In 2001, recognizing the growing need for a cost effective alternative to 24×7 hospital pharmacy staffing, they founded CPA MedNovations, a pioneer in the development and advancement of the pharmacy practice solution after-hours Telepharmacy and today a nationally recognized leader in the category.
Dr. Christopher A. Keeys, Co-founder/President of Clinical Pharmacy Associates, Inc. and CEO of MedNovations, Inc., is a licensed clinical pharmacist, pharmacy executive, researcher and educator who received his B.S. in Pharmacy from Howard University College of Pharmacy and a Doctor of Pharmacy degree from Philadelphia College of Pharmacy. He is board certified in Pharmacotherapy. Chris completed his advanced training as a research intern with the Food and Drug Administration and as a clinician at the Washington Hospital Center. His professional accomplishments include directing the clinical drug studies for a Washington-area research group and leading innovative clinical pharmacy, pharmacy management, drug information and telepharmacy services at more than 60 governmental, private, academic and nonprofit organizations in the USA and internationally. Chris has served on the Boards of the Washington Metropolitan Society of Hospital Pharmacists (President), the Drug Use Review Board for Washington, D.C., and the Chesapeake Research Review, Inc. He has also been a member of the Agency for Healthcare Policy and Research Group on Clinical Practice Guidelines. Since 1996 he has served as a senior pharmacy consultant to the BCBSA Federal Employee Program. Chris is a clinical preceptor for the University of Maryland and holds an adjunct associate professor faculty appointment at Howard University College of Pharmacy, Nursing and Allied Health Science. He has served as a clinical consultant to the DC Department of Health Administration for HIV/AIDS Policy and Programs and the Medicaid Program. He serves as a research fellow at the Howard University Center for Minority Studies and Healthcare Services and is a member of the National Academy of Practitioners. He has lectured and published in the areas of drug information, pharmacy practice, therapeutics, quality improvement, medication errors, formulary management, telepharmacy and patient safety.
Mr. Kenneth Dandurand is Co-Founder and CEO of Clinical Pharmacy Associates, Inc. and Co- Founder and President of MedNovations, where he leads efforts to improve the quality of medication use. He received his B.S. in Pharmacy from Northeastern University, Boston, and completed graduate training (M.S.) in hospital pharmacy and business management from Oregon State University including an ASHP-approved residency at Good Samaritan Hospital in Portland, Oregon. His clinical pharmacy experience in community, hospital, and managed care settings includes roles as leader of the pediatric OB/GYN satellite pharmacy at Massachusetts General Hospital and Director of the Pharmacy Department of Greater Southeast Community Hospital in Washington, D.C. Mr. Dandurand has initiated innovative professional programs by developing extensive clinical pharmacy and drug information service and by spearheading the development of new models for standardized pharmacoeconomic analyses and quality improvement tools to improve the medication use process. He has served on national pharmacy and therapeutics committees for Blue Cross Blue Shield FEP, Rx Management and Pharmacy Direct Network. Mr. Dandurand has published clinical research and authored a chapter in the book Misadventures in Health Care: Inside Stories, Edited by Marilyn Sue Bogner, © 2004 Lawrence Erlbaum Associates. He also served as a clinical faculty member of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Aside from his professional experience, he has a great deal of personal experience with the healthcare system, both as a patient (Melanoma Stage IV) and as a caregiver (wife with Guillain-Barré syndrome and son with Asperger’s Syndrome). In addition he is a current board member for the Autism/Aspergers Network (AANE).
Richard Dandurand, Managing Director, Clinical Pharmacy Associates and MedNovations, Inc. is a business executive with 20 years’ experience running companies in a variety of industries. He received his B.A. in Economics from Clark University and a Masters in Business Administration from Boston University. He completed the Certified Management Accountant program and began his career in accounting and information systems. After leadership roles in implementing operations process change and computer systems, he went on to become President of major divisions and subsidiaries of The Stanley Works, a Fortune 500 company. He has been CEO of an independent publicly traded company, a private equity portfolio company and his own consulting business. Mr. Dandurand has served on the board of directors of Clinical Pharmacy Associates and MedNovations.